At a glance
ClinicalIndex Comparison RecordN/ACompleted· 31 enrolled
Drug / intervention
Cutimed® Sorbact® +1 moredevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
An Exploratory, Single Center, Observer Masked, Active Control, Randomized Trial to Investigate the Effectiveness of Dialkylcarbomoyl Chloride Dressing (Cutimed Sorbact) in Modifying Bacterial Load in Venous Leg Ulcers (VLU)
In Brief
A clinical study evaluating Cutimed® Sorbact® and Acticoat® for Venous Leg Ulcer. Completed, enrolled 31 participants across 1 site.
Detailed Summary
The goal of the study is to investigate the effectiveness of Cutimed Sorbact (Study Device) in modifying bacterial load in venous leg ulcers (VLU).
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsVenous Leg Ulcer
CountriesUnited States
CollaboratorsBSN Medical Inc
Timeline
N/ACompletedFinished
20192020202120222023202420252026
First PostedAug 2018
Enrollment StartAug 2018
Primary CompletionNov 2023
TodayJul 2026
First PostedAug 8, 2018
Enrollment StartAug 22, 2018
Primary CompletionNov 1, 2023
TodayJul 2, 2026
Enrollment to primary: 5.2 yearsPosted 7.9 years ago
Interventions
Cutimed® Sorbact®device
Dialkylcarbomoyl chloride based wound dressing
Acticoat®device
Silver impregnated contact layer dressing